Amplify Energy surges as investors welcome the decision to walk away from a volatile merger with Juniper

How can you spot the best stocks to watch — and weed out the laggards? Start by checking IBD's exclusive Relative Strength (RS) Rating. This telltale metric can help you spot the best stocks to buy and watch in the early stages of a big move.

Here we present five of the best stocks that powered the Nasdaq ETF last week.

The Zacks Medical-Hospital industry is likely to gain from growing demand, improving operating stability and finances. Companies like HCA, THC, UHS and CYH are poised to benefit from these trends.

Rabobank senior cross-asset macro strategist Christian Lawrence joins Catalysts to discuss the weakening US dollar (DX=F, DX-Y.NYB) and its status as the global financial currency. Lawrence also discusses the dollar's role in earnings season, noting that it won't be the "main driver" of earnings this cycle. To watch more expert insights and analysis on the latest market action, check out more Catalysts here.

Yahoo Finance Markets and Data Editor and Stocks in Translation host Jared Blikre compares US stock (^DJI, ^IXIC, ^GSPC) and bond performances (^TYX, ^TNX, ^FVX) throughout history. Catch more Stocks in Translation here, with new episodes every Tuesday and Thursday. To watch more expert insights and analysis on the latest market action, check out more Catalysts here.

Revvity reported first-quarter earnings that topped analysts' estimates.

Shares of CG Oncology catapulted Monday after the biotech unveiled promising results for a J&J-rivaling bladder cancer treatment.

Sabre's sale of its hotel reservations tech should help the travel tech company focus on its core airline business. It's notable that a PE firm rather than a rival player, such as Oracle or Cendyn, chose to buy.

Boeing stock upgraded on growth path. Customer offers to buy halted China jets. Airbus, Spirit AeroSystems agree to facilities deal.